Whitehawk Therapeutics Dividends

WHWK Stock   3.05  0.05  1.67%   
The value of Dividend Yield is estimated to slide to 0.02. The value of Dividend Payout Ratio is estimated to slide to -0.04. Whitehawk Therapeutics' past performance could be the main factor of why investors trade Whitehawk Therapeutics stock today. Investors should clearly understand every aspect of the Whitehawk Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Whitehawk Therapeutics' dividend schedule and payout information. Whitehawk Therapeutics dividends can also provide a clue to the current valuation of Whitehawk Therapeutics.
Last ReportedProjected for Next Year
Dividend Yield 0.02  0.02 
Dividend Payout Ratio(0.04)(0.04)
Dividend Paid And Capex Coverage Ratio(32.40)(34.02)
One of the primary advantages of investing in dividend-paying companies such as Whitehawk Therapeutics is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Whitehawk Therapeutics must own a stock before its ex-dividend date to receive its next dividend.

Whitehawk Therapeutics Dividends Paid Over Time

Today, most investors in Whitehawk Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Whitehawk Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Whitehawk Therapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period.
   Dividends Paid   
       Timeline  

Whitehawk Therapeutics Historical Dividend Yield Growth

A solid dividend growth pattern of Whitehawk Therapeutics could indicate future dividend growth is likely, which can signal long-term profitability for Whitehawk Therapeutics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period.
Dividend Yield is Whitehawk Therapeutics dividend as a percentage of Whitehawk Therapeutics stock price. Whitehawk Therapeutics dividend yield is a measure of Whitehawk Therapeutics stock productivity, which can be interpreted as interest rate earned on an Whitehawk Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
   Dividend Yield   
       Timeline  
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Whitehawk Therapeutics. Anticipated expansion of Whitehawk directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Whitehawk Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.64)
Revenue Per Share
0.28
Quarterly Revenue Growth
0.335
Return On Assets
(0.54)
Return On Equity
(0.14)
Investors evaluate Whitehawk Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Whitehawk Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Whitehawk Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Whitehawk Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Whitehawk Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Whitehawk Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.

Compare Dividends Across Peers

Specify up to 10 symbols: